✦ LIBER ✦

O-261 Polymorphic phase I & phase II enzymes confer a higher risk of NSCLC in Australians

✍ Scribed by Larsen, Jill E.; Colosimo, Maree L.; Yang, Ian A.; Zimmerman, Paul V.; Fong, Kwun M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-017 A Phase I/II trial of erlotinib (E

✍ Thepot, S.; Boehrer, S.; Prebet, T.; Beyne-Rauzy, O.; Wattel, E.; Delaunay, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Combined effect of genetic polymorphisms

✍ Martin Lacko; Adri C. Voogd; Hennie M. J. Roelofs; Rene H. M. te Morsche; Michel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Risk of renal cell carcinoma and polymor

✍ Ahmad, Shiekh Tanveer; Arjumand, Wani; Seth, Amlesh; Nafees, Sana; Rashid, Summy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 428 KB

308 A phase I–II study of the combinatio

✍ Romano, M.; Amichetti, M.; Caffo, O.; Bolner, A.; Pani, G.; Busana, L.; Galligio 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

O-103 A comparison of the antitumour eff

✍ Natale, R.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonp 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase I/II study of the addition of tira

✍ Gatineau, M.; Rixe, O.; Rey, A.; Trandafir, L.; Le Chevalier, T. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 255 KB